In its regular weekly report on measles, the US Centers for Disease Control and Prevention (CDC) today reported 41 more illnesses since its update the previous week, boosting the year's total so far to 981 cases. The CDC added that this year's number so far is the highest in the United States since 1992 and the highest since the disease was eliminated in 2000.
The US Centers for Disease Control and Prevention (CDC) today posted a final investigation update for a Salmonella Reading outbreak that it first announced in July 2018, which reflects 79 new cases since its last report in February, lifting total cases to 358 in 42 states.
With the current resurgence of measles two decades after it was eliminated, the United States is going backward with measles, leading US experts are warning.
Washington state's Clark County, which is part of the Portland, Ore., metropolitan area, has declared a public health emergency related to a measles outbreak, with 22 cases confirmed so far, along with 3 more suspected cases.
The World Health Organization (WHO) yesterday posted a summary of five MERS-CoV cases reported by Saudi Arabia during December, covering new clinical details that weren't included in initial reports.
The Democratic Republic of the Congo (DRC) confirmed three more cases of Ebola and recorded two new deaths in the ongoing outbreak in North Kivu province.
Two of the new cases and both deaths occurred in Beni, the hots pot of the outbreak that saw violent attacks by rebel forces over the weekend. One new case was recorded in Butembo.
The US Food and Drug Administration (FDA) on Oct 5 announced that it approved expanded use of Gardasil 9 human papillomavirus (HPV) vaccine for women and men 27 through 45 years old. The vaccine prevents certain cancers and diseases caused by the nine HPV types contained in the vaccine.
The oropharyngeal cancer rate increased 2.8% per year in men and 0.6% in women.
Preteen girls, teens, and young women who receive recommended vaccinations, including for human papillomavirus (HPV), have no increased risk of primary ovarian insufficiency (POI), also called premature menopause, according to a study published yesterday in Pediatrics.
The value of human papillomavirus (HPV) testing as an additional tool to screen for cervical cancer—joining the traditional Pap smear—has been affirmed by a new meta-analysis and an expert panel’s recommendation based on that analysis, as explained in a set of articles today in the Journal of the American Medical Association (JAMA).